1. Home
  2. PPBT vs WLDS Comparison

PPBT vs WLDS Comparison

Compare PPBT & WLDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • WLDS
  • Stock Information
  • Founded
  • PPBT 2010
  • WLDS 2014
  • Country
  • PPBT Israel
  • WLDS Israel
  • Employees
  • PPBT N/A
  • WLDS N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • WLDS Computer Communications Equipment
  • Sector
  • PPBT Health Care
  • WLDS Telecommunications
  • Exchange
  • PPBT Nasdaq
  • WLDS Nasdaq
  • Market Cap
  • PPBT 2.1M
  • WLDS 2.4M
  • IPO Year
  • PPBT N/A
  • WLDS 2022
  • Fundamental
  • Price
  • PPBT $0.57
  • WLDS $9.42
  • Analyst Decision
  • PPBT Strong Buy
  • WLDS
  • Analyst Count
  • PPBT 1
  • WLDS 0
  • Target Price
  • PPBT $33.00
  • WLDS N/A
  • AVG Volume (30 Days)
  • PPBT 2.8M
  • WLDS 22.6M
  • Earning Date
  • PPBT 08-06-2025
  • WLDS 09-09-2025
  • Dividend Yield
  • PPBT N/A
  • WLDS N/A
  • EPS Growth
  • PPBT N/A
  • WLDS N/A
  • EPS
  • PPBT N/A
  • WLDS N/A
  • Revenue
  • PPBT N/A
  • WLDS $422,000.00
  • Revenue This Year
  • PPBT N/A
  • WLDS N/A
  • Revenue Next Year
  • PPBT N/A
  • WLDS N/A
  • P/E Ratio
  • PPBT N/A
  • WLDS N/A
  • Revenue Growth
  • PPBT N/A
  • WLDS N/A
  • 52 Week Low
  • PPBT $0.53
  • WLDS $1.00
  • 52 Week High
  • PPBT $13.95
  • WLDS $26.40
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 11.95
  • WLDS 96.34
  • Support Level
  • PPBT $0.53
  • WLDS $1.00
  • Resistance Level
  • PPBT $2.36
  • WLDS $10.89
  • Average True Range (ATR)
  • PPBT 0.16
  • WLDS 0.92
  • MACD
  • PPBT -0.13
  • WLDS 0.88
  • Stochastic Oscillator
  • PPBT 2.05
  • WLDS 80.96

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

About WLDS Wearable Devices Ltd.

Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.

Share on Social Networks: